Find the latest news from our company.
Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. PhytoSquene® is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. ... MORE
EUDRACAP® preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. ... MORE
Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology. ... MORE
The cooperation leverages the specific HPAPI competencies of both companies and provides customers with a fully integrated offering from the pre-clinical stage to commercial manufacturing. ... MORE
Evonik’s production site in Ham in northern France has reduced its direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions to zero. It is the first site from the Health Care business at Evonik to go carbon neutral. ... MORE
The dressing epicite® balance is particularly suited and optimized for the treatment of chronic wounds with low to medium exudation. ... MORE
